Find an Animal Health Study

The research team will compare the genetics of dogs diagnosed with multiple cancers with those that are cancer-free, using both previously collected data and samples from the Golden Retriever Lifetime Study.

Researchers will study whether there are subtypes of IMHA and whether those subtypes have different prognoses and optimal therapy.

Researchers will assess how the immune system goes wrong in dogs with IMHA, and the team will study how individual dogs respond to medications available for treatment.

Researchers will look for genetic changes associated with cancer risk in golden retrievers exposed to cigarette smoke.

Researchers will evaluate if trained bio-detection dogs can diagnose hemangiosarcoma from a blood sample.

Researchers will look for genetic variants and other factors that favor longevity and minimize cancer risk in golden retrievers.

Researchers will develop and validate a novel molecular tool to assess residual cancer cell levels in dogs with aggressive T-cell lymphoma to help improve treatment and disease monitoring.